A subset of DNA helicases, the RecQ family, has been found to be associated with the p53-mediated apoptotic pathway and is involved in maintaining genomic integrity. This family contains the BLM and WRN helicases, in which germline mutations are responsible for Bloom and Werner syndromes, respectively. TFIIH DNA helicases, XPB and XPD, are also components in this apoptotic pathway. We hypothesized that there may be some redundancy between helicases in their ability to complement the attenuated p53-mediated apoptotic levels seen in cells from individuals with diseases associated with these defective helicase genes. The attenuated apoptotic phenotype in Bloom syndrome cells was rescued not only by ectopic expression of BLM, but also by WRN or XPB, both 3 0 -5 0 helicases, but not expression of the 5 0 -3 0 helicase XPD. Overexpression of Sgs1, a WRN/BLM yeast homolog, corrected the reduction in BS cells only, which is consistent with Sgs1 being evolutionarily most homologous to BLM. A restoration of apoptotic levels in cells from WS, XPB or XPD patients was attained only by overexpression of the specific helicase. Our data suggest a limited redundancy in the pathways of these RecQ helicases in p53-induced apoptosis.
A subset of DNA helicases, the RecQ family, has been found to be associated with the p53-mediated apoptotic pathway and is involved in maintaining genomic integrity. This family contains the BLM and WRN helicases, in which germline mutations are responsible for Bloom and Werner syndromes, respectively. TFIIH DNA helicases, XPB and XPD, are also components in this apoptotic pathway. We hypothesized that there may be some redundancy between helicases in their ability to complement the attenuated p53-mediated apoptotic levels seen in cells from individuals with diseases associated with these defective helicase genes. The attenuated apoptotic phenotype in Bloom syndrome cells was rescued not only by ectopic expression of BLM, but also by WRN or XPB, both 3 0 -5 0 helicases, but not expression of the 5 0 -3 0 helicase XPD. Overexpression of Sgs1, a WRN/BLM yeast homolog, corrected the reduction in BS cells only, which is consistent with Sgs1 being evolutionarily most homologous to BLM. A restoration of apoptotic levels in cells from WS, XPB or XPD patients was attained only by overexpression of the specific helicase. Our data suggest a limited redundancy in the pathways of these RecQ helicases in p53-induced apoptosis.
Oncogene ( Keywords: helicases; apoptosis; microinjection DNA helicases are enzymes responsible for the separation of complementary strands of nucleic acid molecules. They are classified, based on sequence conservation, into at least five superfamilies (Bachrati and Hickson, 2003) . The SF1 and SF2 are the largest families with the latter containing the RecQ helicases (Tuteja and Tuteja, 2004) . RecQ helicases have a 3 0 -5 0 helicase activity and have roles in DNA recombination and repair (Nakayama, 2002; Bachrati and Hickson, 2003; Hickson, 2003) . Defects in three of the RecQ helicases give rise to diseases characterized by genetic instability and a predisposition to cancer. The three disorders are Bloom syndrome (BS), Werner syndrome (WS), and Rothmund-Thomson syndrome (RTS). The RecQ helicases associated with these syndromes are the BLM, WRN and RECQ4, respectively. WS is also a premature aging disease. Two DNA repair helicases, XPB and XPD, are components of the TFIIH transcription factor. These two subunits of the transcription repair complex have dual roles in transcription activation and initiation, and nucleotide excision repair (Moreland et al., 1999; Tuteja and Tuteja, 2004) . Like the RecQ helicases, XPB unwinds DNA in the 3 0 -5 0 direction, but the XPD helicase functions in the opposite, or 5 0 -3 0 direction. Defects in these two genes are the causative agents in xeroderma pigmentosum (XP) complementation groups B and D, respectively. XP patients exhibit a very high susceptibility to skin cancer.
All of these genetic disorders are autosomal recessive in nature. For the WS phenotype, the syndrome most likely results from the complete loss of function of the WRN gene product because mutations are all across the coding region and result in premature termination of the translation. Mutations in the BLM gene also lead to truncation of the BLM protein and are either nonsense mutations or frameshift mutations that lead to premature termination of the translation. For both WRN and BLM, the nuclear localization signal is at the Cterminus of the protein, indicating that the truncated proteins would not be transported into the nucleus and are presumably degraded in the cytoplasm (Sanz et al., 2003) .
Mutations in either XPB or XPD lead to a reduction in the level of transcription of the TFIIH complex. In XPD, mutations in the C-terminal domain change the TFIIH stoichiometry leading to weaker XPD helicase and kinase activities. XPB mutations inhibit the transcription activity of TFIIH, however, it is unknown if the actual levels of XPB helicase activity are changed due to difficulty in measuring this activity (Coin et al., 1999) .
The tumor suppressor gene, p53, is a key cellular component in maintaining genomic stability. It functions as such by either regulating the cell cycle to allow for DNA repair or inducing apoptosis (Haupt et al., 2003; Hofseth et al., 2004; Lane, 2004) . This ability of p53 to induce apoptosis is regarded as an important function in its role as a tumor suppressor gene (Levine, 1997) . Four of the helicases discussed above, BLM, WRN, XPB and XPD, have been reported to bind to p53 and are involved in the p53-mediated apoptotic pathway (Wang et al., 1996 (Wang et al., , 2001 Spillare et al., 1999; Robles and Harris, 2001) . These helicases were shown to bind to the dephosphorylated C-terminal domain of p53 and it has been suggested that this binding may modulate the induction of p53-mediated apoptosis and possibly DNA repair. These findings were mainly derived from either the use of a microinjection approach or the use of DNA damaging agents that induce p53-mediated apoptosis. Microinjection techniques have been used extensively by us and other laboratories to study biological functions in primary cells (Weeda et al., 1990; van Vuuren et al., 1994; Attardi et al., 1996; Wang et al., 1996 Wang et al., , 2001 van Gool et al., 1997; Spillare et al., 1999; Winkler et al., 2000) . As the SV-40T antigen can bind to and inactivate p53, our studies require the use of primary cells instead of SV-40 immortalized cells. The difficulty of cultivating large number of cells, including those from patients with prematuring aging syndromes, makes it necessary to use this methodology to investigate small populations of cells.
In previous work, we have demonstrated that microinjection of a wild-type p53 expression vector could induce apoptosis in primary human fibroblasts (NHF) (Wang et al., 1996 (Wang et al., , 2001 Spillare et al., 1999) . Under these conditions, it was shown that approximately 22% of the NHFs were apoptotic at 24 h and this rate increased to almost 80% at 72 h. This indicates that most of the normal fibroblasts will undergo apoptosis upon overexpression of p53. In contrast, WS cells will reach a peak of only approximately 30% at 72 h (Spillare et al., 1999) . The time course experiment for the WS cells shows that after 48 h, there is no significant increase in the amount of apoptosis. Therefore, to examine a potential increase or decrease in rates of apoptosis for all cell types, the 24 h time point was chosen to be in a linear range.
Fibroblasts from patients with WS, BS, XPB or XPD have previously been shown to have an attenuated apoptotic response when compared with NHF. Upon overexpression, via microinjection, of the specific helicase for all of these disorders, the attenuated apoptotic response was restored to levels close to that of the NHF, whereas a helicase defective BLM mutant did not (Wang et al., 1996 (Wang et al., , 2001 Spillare et al., 1999) . We hypothesized that there may be some redundancy between helicases in their ability to complement the attenuated apoptosis seen in these genetic instability disorders. As described, we used the microinjection approach to test this hypothesis. The primary cells were seeded on coverslips and microinjected with either the p53 expression vector alone or p53 in combination with a panel of expression vectors containing the helicases. The concentrations of plasmid cDNA were either 200 ng/ml of p53 cDNA alone or 100 ng/ml of p53 cDNA combined with 100 ng/ml of the helicase cDNA. This amount of p53 cDNA injected corresponds to 10 copies of plasmid per cell. After 24 h, the cells were fixed and stained for p53 and the nuclei were stained for DAPI. The level of apoptosis was determined by quantifying the morphological changes seen in the cells that stained positively for p53 expression. These morphological changes included cytoplasmic blebbing and condensation and/or fragmentation of the nuclei. The percent of apoptosis was determined by dividing the amount of p53 immunopositive apoptotic cells by the total number of p53 immunopositive cells. Figure 1 shows a representation of the microinjection results for the NHFs. Cells exhibiting the above-described morphology were confirmed by the TUNEL assay to be apoptotic cells (Supplemental Figure) . The data for all the microinjection experiments are presented in Table 1 . As a control, an equivalent amount of a CMV-driven GFP (green fluorescent protein) expression vector was microinjected and resulted in only 2% apoptosis (Spillare et al., 1999) .
Next, cultured primary WS, BS, XPB and XPD fibroblasts were all microinjected with either p53 alone or p53 plus the varying helicases. We first determined that the attenuated p53-mediated apoptosis seen in previous studies was confirmed for all four cell types. It was also confirmed that overexpression of the helicase specific to the cells from the patients with the disorder associated from its absence could significantly restore the reduced levels of apoptosis. In contrast, overexpression of p53 in combination with any other helicase did not significantly alter the apoptotic levels seen at 24 h in the NHFs (Table 1) .
Our results from the additional microinjections experiments showed that there was complementation for only the BLM RecQ helicase (Table 1) . The BS cells could be corrected not only by BLM, but also by WRN and XPB. There was a statistically significant increase in the amount of apoptosis seen in only the BS cells when comparing microinjections of p53 alone to that of p53 in combination with the BLM, WRN and XPB helicases. This was true for BS cells regardless of p53 background, being seen in either p53-proficient (GM03509) or p53-deficient (GM01492) cells. XPD was the only helicase unable to elevate the amount of p53-mediated apoptosis in the BS cells. It is interesting that the BLM, WRN and XPB helicases translocate in the 3 0 -5 0 direction, while the XPD operates in a 5 0 -3 0 direction. For WS cells, only WRN could correct the attenuated apoptotic phenotype to a significant level. Also, in the case of the two TFIIH helicases, XPB and XPD, only the appropriate helicase could correct the lower levels of apoptosis. These data indicate that there is some redundancy in these helicases, specifically for BLM, which belongs to the RecQ family, in its function associated with p53-mediated apoptosis.
Given the results indicating the BS cells exhibited the ability to be corrected by multiple helicase genes, the yeast helicase belonging to the RecQ helicase family, Sgs1p, was also microinjected into all these cells. Sgs1p is required for the maintenance of genomic stability in Saccharomyces cerevisae (Watt et al., 1996) . Overexpression of Sgs1p was able to correct the attenuated apoptotic response only in the BS cells (Table 1; Figure 2). It did not significantly alter the levels of apoptosis in any other cell type.
Sgs1p is most homologous to BLM and much like BS, sgs1 mutants display elevated rates of recombination, high SCE, and chromosomal rearrangements (Yamagata et al., 1998; Onoda et al., 2000; Myung et al., 2001; Ajima et al., 2002) . Expression of WRN and BLM in sgs1 mutant yeast cells can suppress some of these phenotypes such as hyper-recombination (Yamagata et al., 1998) . Another report shows that BLM, but not WRN, can prevent the premature aging and increased homologous recombination in yeast cells caused by a sgs1 mutation (Heo et al., 1999) . In addition, the sensitivity to hydroxyurea (HU) can be restored in sgs1 mutants by the expression of BLM, but not WRN (Yamagata et al., 1998; Neff et al., 1999) . These results indicate that BLM is more functionally similar to sgs1 than WRN. Our data are consistent with this hypothesis.
It is of interest to note that the yeast RecQ helicase is functional in the p53-mediated apoptotic response in Figure 1 p53-mediated apoptosis in normal fibroblasts. Normal fibroblasts, GM08402 (pictured) as well as fibroblasts from BS, WS and XP patients were microinjected with cDNA expression vectors. The actual cell strains are listed in Table 1 . This figure shows the GM08402 cells microinjected with the wild-type p53 expression vector. Microinjection of cells, fixation and immunocytochemical staining for p53 were performed as previously described (Spillare et al., 1999) . Plasmids used were as follows: pC53SN, encoding the wild-type p53 cDNA, was a gift from Bert Vogelstein (Johns Hopkins University, Baltimore, MD, USA); WRNpbrca WT encoding the wild-type WRN cDNA was a gift from Gerard Schellenberg (Veterans Affairs Puget Sound Health Care System, Seattle, WA, USA); GFP-BLM encodes a wild-type BLM cDNA fused with GFP and received from Nathan Ellis (Memorial Sloan-Kettering Cancer Center, New York, NY, USA); pCEPE3 encoding a wild-type XPB cDNA and pCDNA-XPD encoding a wild-type XPD cDNA were gifts from Jan Hoeijmakers (Erasmus University, Rotterdam, Netherlands); and pCDNA-SGS1, which encodes the full length wild-type SGS1, was received from Ian Hickson (University of Oxford, Oxford, UK). Each experiment was performed in triplicate and a minimum of three times. A control microinjection of the normal cells was carried out for each experiment. Apoptotic cells were scored by morphological changes, including cytoplasmic blebbing and nuclear condensation and/or fragmentation. Panels a, b, and c indicate a cell that was microinjected with p53 and scored as positive for apoptosis, while panels d, e, and f show a nonapoptotic cell immunopositive for p53. human cells. All previous reports have shown the ability of the human helicases to complement functions of SGS1 in yeast cells. The RecQ helicases have been extensively studied in yeast and the high degree of conservation between all RecQ helicases was determined by complementation analysis. Complementation and overexpression studies were able to show WRN and BLM could substitute for SGS1 in suppression of some of the disease associated phenotypes including maintaining telomeric integrity (Lillard-Wetherell et al., 2005) . In this report, we have been able to use a parallel system by substituting a yeast gene, SGS1, the most homologous to BLM, in a human cell assay system.
Our data indicating the complementation of BLM, seen in the BS cells, support the notion that the BLM protein may have an overlapping function with WRN in addition to their distinct roles in DNA metabolism. Not only have BLM and WRN been shown to interact with p53 but they also have both been associated with two other proteins involved in the maintenance of genomic integrity. These proteins are RPA (Brosh et al., 1999 (Brosh et al., , 2000 Sanz et al., 2000) and TRF2 (Johnson et al., 2001; Opresko et al., 2002; Stavropoulos et al., 2002; Machwe et al., 2004) . RPA is a single-strand DNA-binding protein that is required for all aspects of DNA metabolism (Brosh et al., 2000) , while TRF2 binds to double-stranded telomeric DNA throughout the cell cycle and is hypothesized to have a role in the regulation of telomeric length (Fairall et al., 2001) . In addition to being associated with these proteins, BLM and WRN are known to have a physical and functional interaction with each other (Von . BLM and WRN colocalize to nuclear foci, can be coimmunoprecipitated, and the purified proteins functionally interact (Von . Both the BLM and WRN proteins have been implicated in having roles in homologous recombination (Saintigny et al., 2002; Wu and Hickson, 2003) . These data indicate the two proteins may function together in a complex that is involved in DNA metabolism.
Further studies need to be carried out to investigate the overlapping roles of WRN and BLM in the apoptotic pathway and the importance of this redundancy. The helicase enzyme activity of these particular proteins appears to be a requirement for induction of p53-mediated apoptosis since we have previously shown that a BLM helicase-deficient mutant did not rescue the p53-mediated apoptotic phenotype in BS cells (Wang et al., 2001) . The helicase domain is highly conserved among the RecQ helicase family (van Brabant et al., 2000) . The observation that WRN can rescue the p53-mediated apoptotic phenotype in both WS and BS cells but BLM cannot rescue WS cells is consistent with the previous results in which either WRN or BLM can rescue sgs1 deficient cells (Lillard-Wetherell et al., 2005) and our data indicating the sgs1 can rescue only BS cells (Figure 2 ). Therefore, a functional 3 0 -5 0 helicase (WRN, BLM, SGS1 or XPB) is sufficient to rescue BS cells. The rescue of the p53-mediated apoptotic phenotype in WS and XPB cells is more complex and may reflect the fact that WRN has evolved from BLM including obtaining an exonuclease domain and XPB is only distantly related to the RecQ helicase family. Further studies, such as forming chimeric genes by switching different functional domains among these helicases, are needed to identify the differences in the p53-mediated apoptotic pathways among cells from these different syndromes.
In summary, by using a technique that we and others have used extensively to examine nucleotide excision repair and apoptosis, we have been able to look at complementation of DNA helicases in a human cell system much like the complementation studies carried out in yeast. It has been postulated that WRN and BLM may have overlapping pathways in DNA metabolism and here we show that the shared functions may include apoptosis. However, BLM and WRN are not functionally redundant in modulating p53-mediated apoptosis. and the helicase defective cells were all microinjected as described (Spillare et al., 1999) with either p53 alone or p53 plus the helicase expression vectors. Cells were fixed and stained for p53 and the nuclei were stained for DAPI after 24 h. Three independent experiments were performed for each cell type. The percent of apoptotic cells was determined and the results were graphed. The percent increase in apoptosis of p53/SGS1 versus p53 alone is statistically significant (*) for only the BS cells (both GM01492 and GM03509). None of the other cell types exhibited a correction in the attenuated p53-apoptotic phenotype.
